West Pharmaceutical Services, Inc. (WST) |
| 263.88 3.92 (1.51%) 04-14 10:46 |
| Open: | 261.18 |
| High: | 264.55 |
| Low: | 260.79 |
| Volume: | 54,694 |
| Market Cap: | 19,005(M) |
| PE Ratio: | 38.81 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 311.52 |
| Resistance 1: | 266.71 |
| Pivot price: | 253.79 |
| Support 1: | 243.03 |
| Support 2: | 228.40 |
| 52w High: | 322.34 |
| 52w Low: | 193.05 |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
| EPS | 6.790 |
| Book Value | 44.110 |
| PEG Ratio | 0.00 |
| Gross Profit | 15.261 |
| Profit Margin (%) | 16.06 |
| Operating Margin (%) | 21.64 |
| Return on Assets (ttm) | 10.1 |
| Return on Equity (ttm) | 16.9 |
Mon, 13 Apr 2026
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Sat, 11 Apr 2026
WST (West Pharmaceutical Services) Policyholder Funds - GuruFocus
Thu, 09 Apr 2026
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Thu, 09 Apr 2026
West to Host First-Quarter 2026 Conference Call - Finviz
Thu, 09 Apr 2026
West Pharmaceutical to post Q1 results before April 23 webcast - Stock Titan
Fri, 03 Apr 2026
Is It Too Late To Reconsider West Pharmaceutical Services (WST) After Its Recent Share Price Rebound? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |